Home › hepatitis
 

Keywords :   


Tag: hepatitis

FDA: J&J hepatitis C drug cures 80% of patients

2013-10-22 17:22:36| Biotech - Topix.net

An experimental hepatitis C drug from Johnson & Johnson appears to be slightly more effective at eliminating the virus than currently available treatments, though federal safety reviewers say it also causes rash and sunburn in some patients.

Tags: of drug patients fda

 

FDA: J&J hepatitis C drug cures 80 pct of patients

2013-10-22 17:03:09| Food - Topix.net

An experimental hepatitis C drug from Johnson & Johnson appears to be slightly more effective at eliminating the virus than currently available treatments, though federal safety reviewers say it also causes rash and sunburn in some patients.

Tags: of drug patients pct

 
 

Data from Mercks Investigational Hepatitis C Treatment Portfolio to be Presented at the 64th American Association for the Study of Liver Diseases Annual Meeting

2013-10-01 16:00:00| Merck.com - Research & Development News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of data from studies evaluating the companys investigational oral chronic hepatitis C virus (HCV) treatments MK-5172 and MK-8742 at the 64th American Association for the Study of Liver Diseases Annual Meeting (AASLD). The meeting is scheduled to take place in Washington, D.C., Nov. 1-5, 2013. Language: English Contact: MerckMedia:Sarra Herzog, 908-423-6154orInvestor:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: of data american study

 

Vertex sinks after FDA freezes portion of hepatitis drug trial

2013-07-26 19:57:48| Biotech - Topix.net

Investors pounded Vertex Pharmaceuticals in after-hours trading Thursday after the company announced that the U.S. Food and Drug Administration had placed a partial hold on a drug trial for a hepatitis C therapy that may have contributed to liver toxicity in some patients.

Tags: trial drug portion fda

 

Israel's SciVac eyes global expansion of 3G hepatitis B vaccine

2013-07-25 17:54:40| Biotech - Topix.net

Israeli drug company SciVac is seeking U.S. approval for a widely used hepatitis B vaccine as part of a push for increased global sales of a product which it says could stem global growth in the disease.

Tags: global eyes expansion hepatitis

 

Sites : [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] next »